Cargando…
Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140747/ https://www.ncbi.nlm.nih.gov/pubmed/32173794 http://dx.doi.org/10.1007/s12325-020-01274-5 |
| _version_ | 1783519061459599360 |
|---|---|
| author | Moran, Kellyn Null, Kyle Huang, Zhongwen Lissoos, Trevor Kane, Sunanda |
| author_facet | Moran, Kellyn Null, Kyle Huang, Zhongwen Lissoos, Trevor Kane, Sunanda |
| author_sort | Moran, Kellyn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7140747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71407472020-04-14 Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” Moran, Kellyn Null, Kyle Huang, Zhongwen Lissoos, Trevor Kane, Sunanda Adv Ther Letter Springer Healthcare 2020-03-15 2020 /pmc/articles/PMC7140747/ /pubmed/32173794 http://dx.doi.org/10.1007/s12325-020-01274-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter Moran, Kellyn Null, Kyle Huang, Zhongwen Lissoos, Trevor Kane, Sunanda Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title | Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title_full | Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title_fullStr | Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title_full_unstemmed | Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title_short | Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” |
| title_sort | response to “comment on retrospective claims analysis indirectly comparing medication adherence and persistence between intravenous biologics and oral small-molecule therapies in inflammatory bowel diseases” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140747/ https://www.ncbi.nlm.nih.gov/pubmed/32173794 http://dx.doi.org/10.1007/s12325-020-01274-5 |
| work_keys_str_mv | AT morankellyn responsetocommentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases AT nullkyle responsetocommentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases AT huangzhongwen responsetocommentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases AT lissoostrevor responsetocommentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases AT kanesunanda responsetocommentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases |